22157.jpg
Asia-Pacific Respiratory Devices Market Report 2020-2025: Market Breakdown by Diagnostic and Monitoring Devices, Therapeutic Devices & Disposables
14 oct. 2020 04h14 HE | Research and Markets
Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Asia-Pacific Respiratory Devices Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global Smart Inhalers Markets, 2019-2024 with 2018 as the Base Year: Focus on Asthma and COPD with COVID-19 Impact Analysis
07 oct. 2020 06h14 HE | Research and Markets
Dublin, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The "Smart Inhalers: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report offers a comprehensive picture of the...
RYAH Logo.png
RYAH Inhaler Passes Major Safety Test Milestone
05 déc. 2019 07h00 HE | RYAH
NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that it has passed CE-RED NB and IEC 60601 medical device safety tests, which brings RYAH...
adherium_logo.jpg
Adherium Announces Participation in SmartAirLA Effort to Combat Asthma in Los Angeles with Support from Blue Shield of California Foundation
03 oct. 2018 06h00 HE | Adherium North America Inc
SAN MATEO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a leading digital health platform for medication adherence today announced its participation in the launch of the SmartAirLA...
SmartAirLA_logo.jpg
SmartAirLA Awarded $250k to Pilot “Smart” Inhaler Program for Underserved Children in Los Angeles
03 oct. 2018 06h00 HE | SmartAirLA
Part of Blue Shield of California Foundation’s $3.5 million grantmaking to assess the value of prevention in community health. LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Blue Shield of...
adherium_logo.jpg
Adherium Announces Program with Vitalus Health on World Asthma Day
01 mai 2018 07h30 HE | Adherium North America Inc
SAN MATEO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- In conjunction with World Asthma Day, Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes,...
MON AC FlowVU Pt Sheet 11 27 17[1]
Landmark asthma study demonstrates device choice determines asthma control
30 nov. 2017 08h45 HE | Monaghan Medical Corporation
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an...